AKT1 and gallbladder cancer: Liu et al. unraveled that SIRT3 silencing could inhibit Akt-dependent death in gallbladder cancer cell lines; vice versa, overexpression of SIRT3 boosted ferroptosis in gallbladder cancer cells and repressed tumor initiation and progression (Liu et al., 2021b).